This Notice explains how we process (e.g. collect, use, store, and share) your personal data when you are in dialogue with us via iCARE chatbot. We will process any personal data about you in accordance with this notice and with applicable law.
The companies responsible for processing your personal data are:
Novo Nordisk Kenya Limited
7th Floor, The Convex Building,
Riverside lane, Riverside,
Nairobi, Kenya
Nordisk Pharma Limited
4th Floor GIL Group Building, 10
Gbolahan Lawal close, Off Ashabi Cole Street
Alausa CBD, Ikeja
Lagos, Nigeria
You can always contact Novo Nordisk Kenya Limited and Novo Nordisk Pharma Limited Data Privacy Officer at privacyma@novonordisk.com with questions or concerns about how we process your personal data.
We get your personal data from you directly in your dialogue with iCARE chatbot.
We process personal data about you for the following purposes:
You are not required to provide us with your personal data. If you do not want Novo Nordisk to use your personal data, we will not be able to provide you with disease awareness information through iCARE chatbot.
For the purposes described above in Section 3, we may process the following types of personal data if provided by you:
Our processing of your personal data requires a legal basis.
By law we are allowed to process your personal data described above in Section 4 based on the following legal bases:
Your information is strictly confidential and will be treated as such. A very limited number of individuals will have access to this information, when this data is reported, it is aggregated and anonymized.
We may share your personal data with: In the course of our activities and for the same purposes as those listed in this Privacy Notice, your personal data can be accessed by, or transferred to the following categories of recipients, on a need-to-know basis to achieve such purposes:
Suppliers or vendors that assist our company (e.g., customer services, consultants, IT service providers, financial institutions, law firms, license partners).
Other Novo Nordisk entities.
Public authorities including health and /or regulatory authorities if needed.
Our safety team for follow-up on safety concerns.
We will keep your personal data for:
For a period of 90 days from date of first dialogue with iCARE chatbot.
For data related to side effects, your personal data will be entered into the Novo Nordisk global safety database and will be treated confidentially. Data will be kept until end of activity + 10 years.
For technical complaints of Novo Nordisk medicinal products, your personal data will be entered and kept permanently in the Novo Nordisk global safety database and will be treated confidentially.
In general, you have the following rights:
Under applicable law, there may be limits on these rights depending on the specific circumstances of the processing activity. Contact us as described in Section 1 with questions or requests relating to these rights